Person: SÖYLEMEZ, MEHMET ALİ
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Job Title
Last Name
SÖYLEMEZ
First Name
MEHMET ALİ
Name
14 results
Search Results
Now showing 1 - 10 of 14
Publication Metadata only The use of long-range pcr protocol in the diagnosis of friedreich ataxia(2020-11-22) ALAVANDA, CEREN; POLAT, HAMZA; SÖYLEMEZ, MEHMET ALİ; GEÇKİNLİ, BİLGEN BİLGE; ATA, PINAR; ARMAN, AHMET; ALAVANDA C., POLAT H., DEMİR Ş., ARSLAN ATEŞ E., SÖYLEMEZ M. A., GEÇKİNLİ B. B., ATA P., ARMAN A.Introduction: Friedreich ataxia(FRDA) is multisystemic disorder characterized by trinucleotide expansions in FXN gene. It’s one of the most common causes of autosomal recessive ataxia. Material/Method: Fragment analysis method was used to detect GAA triple nucleotide repeat expansions in the first intron of the FXN gene. Long-range PCR was performed with primers selected from both in intron and exon for confirmation in patients with more than two hundred repeats. Results: Fragment analysis was performed in 20 patients with FRDA pre-diagnosis. Long-range PCR was performed in 5 patients with more than 200 GAA repeats. After long-range PCR, the number of repetitions between 180 and 1450 was found in these patients. One allele of two siblings whose fragment analysis gave negative results was found to have an approximately 950 repeats. FXN gene sequence analysis was planned in order not to miss point mutations in patients with negative results. In order to provide appropriate genetic counseling to patients, segregation studies are continuing. Discussion: Although fragment analysis is reliable method in this disease, its reliability decreases when the number of repeats is high. Although Southern-blot method can be used for confirmation, long-range PCR protocols which are cheaper and easier, can also be applied.Publication Open Access Novel, homozygous RAB3GAP1 c.2606 + 1G>A, p.Glu830ValfsTer9 variant and chromosome 3q29 duplication in a Turkish individual with Warburg micro syndrome(2023-04-01) ALAVANDA, CEREN; SÖYLEMEZ, MEHMET ALİ; ARMAN, AHMET; Geckinli B., TÜRKYILMAZ A., ALAVANDA C., Sager G., Arslan Ates E., SÖYLEMEZ M. A., ARMAN A.Warburg micro syndrome (WARBM) is a rare, autosomal recessive, neurodevelopmental disorder characterized by microcephaly, cortical dysplasia, corpus callosum hypoplasia, congenital hypotonia leading to subsequent spastic quadriplegia, severe developmental delay and hypogenitalism. Ophthalmologic findings that may affect any ocular segment including characteristic, small, atonic pupils. WARBM is known to be caused by biallelic, pathogenic variants in at least five genes although additional genetic loci may exist. The RAB3GAP1 c.748 + 1G>A, p.Asp250CysfsTer24 founder variant has been described in families of Turkish ancestry. We report the clinical and molecular findings in three, unrelated, Turkish families with WARBM. A novel c.974-2A>G variant causing WARBM in three siblings of Turkish descent was found. Functional studies of the novel, c.2606 + 1G>A variant in patients\" mRNA revealed skipping of exon 22 which results in a premature stop codon in exon 23. However, the clinical consequences of this variant are blended given that the individual also had a maternally inherited chromosome 3q29 microduplication.Publication Metadata only A recurrent HPS1 gene mutation in a Hermansky-Pudlak patient with uncommon clinical presentation(2020-02-22) SÖYLEMEZ, MEHMET ALİ; GEÇKİNLİ, BİLGEN BİLGE; GÜNEY, AHMET İLTER; ATA, PINAR; ARMAN, AHMET; ALAVANDA C., ARSLAN ATEŞ E., POLAT H., İlker A., Yıldırım Ö., SÖYLEMEZ M. A., GEÇKİNLİ B. B., GÜNEY A. İ., ATA P., ARMAN A.Publication Metadata only ZBTB24 novel mutation identified in Turkish ICF syndrome patient(2020-02-22) SÖYLEMEZ, MEHMET ALİ; GEÇKİNLİ, BİLGEN BİLGE; GÜNEY, AHMET İLTER; ATA, PINAR; ARMAN, AHMET; İlker A., POLAT H., ALAVANDA C., Yıldırım Ö., ARSLAN ATEŞ E., SÖYLEMEZ M. A., GEÇKİNLİ B. B., GÜNEY A. İ., ATA P., ARMAN A.Publication Metadata only Two new cases diagnosed with Hermansky-Pudlak Syndrome(2021-08-28) GEÇKİNLİ, BİLGEN BİLGE; SÖYLEMEZ, MEHMET ALİ; ATA, PINAR; ARMAN, AHMET; ALAVANDA C., ARSLAN ATEŞ E., GEÇKİNLİ B. B., Demir Ş., POLAT H., UĞUZDOĞAN F., SÖYLEMEZ M. A., ATA P., ARMAN A.Publication Metadata only Schimke immuno-osseous dysplasia patient with early renal dysfunction harboring a novel homozygous mutation in the SMARCAL1 gene(2021-09-18) SÖYLEMEZ, MEHMET ALİ; GEÇKİNLİ, BİLGEN BİLGE; GÜNEY, AHMET İLTER; ATA, PINAR; ARMAN, AHMET; ALAVANDA C., Demir Ş., UĞUZDOĞAN F., POLAT H., ARSLAN ATEŞ E., SÖYLEMEZ M. A., GEÇKİNLİ B. B., GÜNEY A. İ., ATA P., ARMAN A.Main findings of this syndrome are steroid resistant nephrotic syndrome (SRNS), immunodeficiency and spondyloepiphyseal dysplasia (SED). Biallelic mutations in SMARCAL1 gene cause SIOD. SMARCAL1 encodes a conserved ATP-dependent chromatin remodeling protein which is a member of Sucrose Non-Fermenting 2(SNF2) family. Case: One-year-old female referred to our clinic because of having growth retardation and developmental delay. Her parents were from the same small village. She was delivered prematurely due of preeclampsia. In neonatal intensive care unit cardiac and renal anomalies were detected. Eruption of deciduous teeth were delayed. Fine hair, microcephaly, prominent forehead, malar hypoplasia, depressed nasal bridge, bulbous nasal tip, long philtrum, thin upper lip, everted lower lip, microdontia, anteverted ears, short neck and trunk, hyperpigmented macules on trunk, protruding abdomen, tapering fingers, brachydactyly were detected. She was diagnosed with SRNS. Skeletal survey showed platyspondyly, scoliosis, shallow acetabular fossae. No pathology was observed in the epiphyses. After DNA isolation from the peripheral blood, clinical exome sequencing were performed via next-generation-sequencing. Novel homozygous c.2423_2427+9delCCAGGGGTAAGAGA mutation in the SMARCAL1 gene(NM_001127207) was detected. According to ACMG criterias it was pathogenic(PVS1,PM2, PP3). Her parents were heterozygous. Discussion/ Conclusion: SIOD is characterized with short stature,SED,immune deficiency,SRNS and dysmorphic findings. SIOD had classified into severe and mild types. In severe patients, infections, cerebrovascular disease and renal phenotype present at an earlier age. Our patient had a severe phenotype as she carried a truncating mutation. This study reveals a novel mutation and contributes to the genotype-phenotype correlation for SIOD.Publication Open Access First patient diagnosed as feingold syndrome type 2 with alport syndrome and review of the current literature(2022-12-01) ARMAN, AHMET; ATA, PINAR; SÖYLEMEZ, MEHMET ALİ; Demir S., SÖYLEMEZ M. A., ARMAN A., ATA P.Introduction: Feingold syndrome type 2 (FGLDS2) is an ultra-rare genetic disorder characterized by short stature, microcephaly, digital abnormalities, and intellectual disability. Until now, 22 patients have been reported in the literature. FGLDS2 is caused by a germline heterozygous deletion of 13q resulting in haploinsufficiency of the MIR17HG gene. Case report: In the present study, we evaluated clinical, radiological, and genetic analyses of a 10-year-old Turkish-origin girl with short stature, brachydactyly, intellectual disability, hematuria, and proteinuria. Conclusion/Discussion: In the array-CGH analysis, a 15.7-Mb deletion, arr[hg19] 13q22q31.3(78,241,132_93,967,288)x1, was detected, and this alteration was evaluated to be pathogenic. The deletion of this region covering the MIR17HG gene is a potential cause of FGLDS2. Also, at her clinical exome sequencing study, a heterozygous c.2023G>A p.(Gly675Ser) variation was detected in the COL4A5 gene (NM_000495.4) that was likely pathogenic in up-to-date databases. As a result, we report on a patient who has FGLDS2 and Alport syndrome. This is the first report of a Turkish-origin FGLDS2 patient. Reporting new cases expands the range of phenotypes, plays a crucial role in understanding the FGLDS2 pathogenesis, and is important in terms of screening at-risk family members for giving appropriate genetic counseling and preimplantation genetic diagnosis opportunities.Publication Metadata only Kompleks genotipe sahip bir retinitis pigmentoza olgusu(2020-11-22) GEÇKİNLİ, BİLGEN BİLGE; SÖYLEMEZ, MEHMET ALİ; ATA, PINAR; ARMAN, AHMET; ARSLAN ATEŞ E., DEMİR Ş., GEÇKİNLİ B. B., YILDIRIM Ö., POLAT H., ALAVANDA C., SÖYLEMEZ M. A., ATA P., ARMAN A.Amaç: Retinitis Pigmentoza (RP) retinal fotoreseptör anormallikleri nedeniyle ilerleyici görme kaybı ile karakterize kalıtımsal bir hastalıktır. Genetik olarak oldukça heterojen olup otozomal resesif(OR), otozomal dominant(OD), X’e bağlı resesif, nadiren digenik olarak kalıtılabilmektedir. Bu çalışmada birinde bialelik, diğerinde monoalelik olmak üzere iki farklı gende klinik durumla ilişkili mutasyon saptadığımız nonsendromik bir RP olgusu sunulmaktadır. Olgu: RP ön tanısıyla tarafımıza yönlendirilen 25 yaşında erkek olgu, ilk kez 5 yaşında başlayan ve giderek artan görme kaybı tariflemekteydi. Ebeveynleri arasında akraba evliliği tanımlamayan hastanın ailesinde benzer öykü yoktu. Oftalmolojik bakısı tipik RP bulguları gösteren olgunun sistemik değerlendirmesinde başka bir bulgu saptanmadı. Nonsendromik RP tanısıyla RP ile ilişkilendirilmiş 73 gen yeni nesil dizileme yöntemiyle tarandı. Yapılan analizde olguda OR RP ile ilişkilendirilmiş PROM1 geninde homozigot c.2023C>T(p.Arg675*) ve OD RP ile ilişkilendirilmiş PRPF8 geninde heterozigot c.4980C>G (p.Tyr1660*) mutasyonları saptandı. Veritabanlarında ve popülasyon çalışmalarında saptanmamış nadir bir varyasyon olan PRPF8 c.4980C>G varyasyonu ACMG kriterlerine göre patojenik olarak değerlendirildi. Segregasyon analizi ve aile taraması planlandı. Sonuç: RP hastalarının genetik heterojenite ve farklı kalıtım özellikleri nedeniyle altta yatan moleküler defekt açısından geniş paneller ile değerlendirilmesi nadiren de olsa hastamızda olduğu gibi iki farklı moleküler defektin gözden kaçmaması için önemli olup daha etkin bir genetik danışma verilmesine olanak sağlamaktadır.Publication Metadata only Revealing novel splicing mutations in RAB3GAP1 gene causing Warburg Micro syndrome and a case including microduplication of 3q29(2020-06-25) GEÇKİNLİ, BİLGEN BİLGE; SÖYLEMEZ, MEHMET ALİ; ARMAN, AHMET; GEÇKİNLİ B. B., TÜRKYILMAZ A., ALAVANDA C., TAŞLIDERE H., SAĞER S. G., ARSLAN ATEŞ E., SÖYLEMEZ M. A., ARMAN A.Publication Metadata only Whole-exome sequencing reveals new potential genes and variants in patients with premature ovarian insufficiency(SPRINGER/PLENUM PUBLISHERS, 2022) ARMAN, AHMET; Turkyilmaz, Ayberk; Alavanda, Ceren; Ates, Esra Arslan; Geckinli, Bilgen Bilge; Polat, Hamza; Gokcu, Mehmet; Karakaya, Taner; Cebi, Alper Han; Soylemez, Mehmet Ali; Guney, Ahmet Ilter; Ata, Pinar; Arman, AhmetPurpose Premature ovarian insufficiency (POI) is a heterogeneous disorder characterized by the cessation of menstrual cycles before the age of 40 years due to the depletion or dysfunction of the ovarian follicles. POI is a highly heterogeneous disease in terms of etiology. The aim of this study is to reveal the genetic etiology in POI patients. Methods A total of 35 patients (mean age: 27.2 years) from 28 different families diagnosed with POI were included in the study. Karyotype, FMR1 premutation analysis, single nucleotide polymorphism (SNP) array, and whole-exome sequencing (WES) were conducted to determine the genetic etiology of patients. Results A total of 35 patients with POI were first evaluated by karyotype analysis, and chromosomal anomaly was detected in three (8.5%) and FMR1 premutation was detected in six patients (17%) from two different families. A total of 29 patients without FMR1 premutation were included in the SNP array analysis, and one patient had a 337-kb deletion in the chromosome 6q26 region including PARK2 gene, which was thought to be associated with POI. Twenty-nine cases included in SNP array analysis were evaluated simultaneously with WES analysis, and genetic variant was detected in 55.1% (16/29). Conclusion In the present study, rare novel variants were identified in genes known to be associated with POI, which contribute to the mutation spectrum. The effects of detected novel genes and variations on different pathways such as gonadal development, meiosis and DNA repair, or metabolism need to be investigated by experimental studies. Molecular etiology allows accurate genetic counseling to the patient and family as well as fertility planning.